ARID1A and breast cancer: While none of the featured ARID1A-dependent genes are frequently altered in advanced invasive or metastatic breast cancers, the responses detected in immortalized but untransformed epithelial cells suggest that Bex+Carv may suppress a pro-carcinogenic signal and the acquisition of invasive capabilities.